BIO-TECHNE Corp
Bio-Techne Corporation is a Minnesota-based company with global headquarters in Minneapolis. It was founded in 1976 and became a publicly traded company in 1985. The company develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. Bio-Techne operates in two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment offers specialized proteins, antibodies, small molecules, tissue culture sera, and cell selection technologies for research use and next-generation diagnostics and therapeutics. It also provides protein analysis instruments and immunoassays used in quantifying proteins in various biological fluids. The segment's products are used by researchers in academia and industry, diagnostic/companion diagnostic and therapeutic customers, and production and quality control departments at biotech and pharmaceutical companies. The Diagnostics and Genomics segment focuses primarily on the diagnostics market and includes spatial biology, liquid biopsy, molecular diagnostics kits and products, and diagnostics reagents. The segment's products are used by researchers in academia and pharmaceutical and biotech companies, as well as in clinical settings for diagnostics and research purposes. Bio-Techne's website is www.bio-techne.com, and its common stock is listed on the NASDAQ under the symbol "TECH."